Teladoc Health (TDOC) Research & Development (2014 - 2026)

Teladoc Health's Research & Development history runs 13 years deep, the most recent figure standing at $67.9 million for Q1 2026.

• In Q1 2026, Research & Development fell 2.99% year-over-year to $67.9 million; the TTM figure through Mar 2026 stood at $275.8 million (down 6.77% YoY), while the FY2025 annual figure was $277.9 million, down 9.55% from the prior year.
• Research & Development came in at $67.9 million for Q1 2026 at Teladoc Health, down from $71.6 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $89.9 million in Q4 2023 to a low of $67.6 million in Q3 2025.
• A 5-year average of $78.5 million and a median of $78.7 million in 2022 frame the typical range for Research & Development.
• Across the five-year window, Research & Development increased 13.81% in 2022 and dropped 14.66% in 2024, its largest moves.
• Teladoc Health's Research & Development stood at $82.9 million in 2022, then increased by 8.45% to $89.9 million in 2023, then slipped by 14.66% to $76.8 million in 2024, then declined by 6.7% to $71.6 million in 2025, then declined by 5.23% to $67.9 million in 2026.
• According to Business Quant data, Research & Development over the past three periods registered $67.9 million, $71.6 million, and $67.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison